AtriCure, Inc. Cash Flow Statement
ATRC / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
AtriCure, Inc. generated $57M in operating cash flow and $48M in free cash flow in FY2025. Free cash flow margin was 9.0% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Negative profit margin: -9.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$11.4M | -$44.7M | -$30.4M | -$46.5M | $50.2M | -$48.2M | -$35.2M | -$21.1M | -$26.9M | -$33.3M | -$27.2M | -$16.2M | -$11.5M | -$7.5M | -$5.5M |
| Operating Cash Flow | $57.3M | $12.2M | $4.5M | -$22.1M | -$13.8M | -$19.9M | -$15.8M | -$4.2M | -$8.9M | -$15.1M | -$7.8M | -$21.6M | -$5.2M | -$1.9M | -$2.0M |
| Capital Expenditures | $9.1M | $11.5M | $12.0M | $16.9M | $9.8M | $5.3M | $12.2M | $6.2M | $6.4M | $7.7M | $13.4M | $5.5M | $2.9M | $3.0M | $1.5M |
| Free Cash Flow | $48.3M | $745.0K | -$7.5M | -$39.0M | -$23.5M | -$25.1M | -$28.0M | -$10.4M | -$15.3M | -$22.8M | -$21.3M | -$27.1M | -$8.1M | -$4.9M | -$3.5M |
| FCF Margin | 9.0% | 0.2% | -1.9% | -11.8% | -8.6% | -12.2% | -12.1% | -5.1% | -8.8% | -14.7% | -16.4% | -25.2% | -9.9% | -7.0% | -5.5% |